Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
1510
Trial Sponsor
Clinical Trial Start Date
February 28, 2018
0Primary Completion Date
April 30, 2020
0Study Completion Date
April 30, 2020
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Prospective0
Participating Facility
Official Name
Prospective Observational Study on Overall Survival and Quality of Life in Patients Older Than 60 Years With Acute Myeloid Leukemia Diagnosis in Spain, Treated According to Standard Clinical Practice0
Last Updated
May 21, 2021
0Study summary
Prospective, multicenter, observational, national study (EPA-SP) that aims to describe the survival and the quality of life, the clinical management strategies and the prognostic factors for survival related to the patient, in a prospective cohort of patients over 60 with AML diagnosis in Spain and treated outside of clinical trials; that is, under conditions of standard clinical practice. The study will last 24 months in total from the inclusion of the first patient until the end of the last patient's follow-up
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
